IBBQ
IBBQ
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 9.27% | 48.41K | $6.96M |
 VRTX | Vertex Pharmaceuticals Incorporated | 8.99% | 14.05K | $6.75M |
 AMGN | Amgen Inc. | 8.97% | 17.64K | $6.69M |
 REGN | Regeneron Pharmaceuticals, Inc. | 5.95% | 5.79K | $4.46M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.26% | 7.40K | $2.45M |
 INSM | Insmed Incorporated | 2.39% | 11.95K | $1.79M |
 BIIB | Biogen Inc. | 2.06% | 8.21K | $1.54M |
 ARGX | argenx SE | 1.67% | 1.63K | $1.25M |
 UTHR | United Therapeutics Corporation | 1.62% | 2.41K | $1.22M |
 MRNA | Moderna, Inc. | 1.51% | 21.88K | $1.13M |
 ROIV | Roivant Sciences Ltd. | 1.48% | 38.98K | $1.11M |
 RVMD | Revolution Medicines, Inc. | 1.47% | 10.84K | $1.11M |
 INCY | Incyte Corporation | 1.47% | 10.99K | $1.10M |
 RPRX | Royalty Pharma plc | 1.45% | 23.95K | $1.09M |
 ILMN | Illumina, Inc. | 1.45% | 8.56K | $1.09M |
 VTRS | Viatris Inc. | 1.31% | 64.55K | $984.43K |
 ASND | Ascendis Pharma A/S | 1.05% | 3.44K | $787.27K |
 BBIO | BridgeBio Pharma, Inc. | 0.97% | 10.81K | $730.93K |
 IONS | Ionis Pharmaceuticals, Inc. | 0.97% | 9.06K | $730.40K |
 NBIX | Neurocrine Biosciences, Inc. | 0.97% | 5.58K | $728.84K |
SECTOR HOLDINGS
Healthcare
Cash & Others
Financial ServicesASSET ALLOCATION BY REGION
United States
Netherlands
United Kingdom
France
Ireland
Denmark
Germany
Canada
Switzerland
Singapore
Bermuda
Jersey
Iceland
Spain
Cayman Islands
China
Australia
Israel
Belgium.svg)
Taiwan (Province of China)SECTOR HOLDINGS
Healthcare Cash & Others Financial ServicesASSET ALLOCATION BY REGION
United States Netherlands United Kingdom France Ireland Denmark Germany Canada Switzerland Singapore Bermuda Jersey Iceland Spain Cayman Islands China Australia Israel Belgium Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
AMGN
Amgen Inc.
REGN
Regeneron Pharmaceuticals, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
INSM
Insmed Incorporated
BIIB
Biogen Inc.
ARGX
argenx SE
UTHR
United Therapeutics Corporation
MRNA
Moderna, Inc.
ROIV
Roivant Sciences Ltd.
RVMD
Revolution Medicines, Inc.
INCY
Incyte Corporation
RPRX
Royalty Pharma plc
ILMN
Illumina, Inc.
VTRS
Viatris Inc.
ASND
Ascendis Pharma A/S
BBIO
BridgeBio Pharma, Inc.
IONS
Ionis Pharmaceuticals, Inc.
NBIX
Neurocrine Biosciences, Inc.